USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2011 |
---|---|---|---|---|---|---|
Operating Cash Flow | -36.51 Thousand | -32.35 Thousand | -35.63 Thousand | 36.60 | 36.60 | -198.79 Thousand |
Net Income | -92.22 Thousand | -95.3 Thousand | -111 Thousand | -36.6 Thousand | -36.60 | -152.79 Thousand |
Depreciation & Amortization | - | - | - | - | - | 592.00 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 39.9 Thousand | - | - | - |
Change in working capital | 55.71 Thousand | 62.95 Thousand | 39.73 Thousand | 36.6 Thousand | 36.00 | -46.59 Thousand |
Other non-cash items | -4.29 | 1.79 | -4270.00 | 36.60 | 0.60 | 73.78 Thousand |
Investing Cash Flow | - | - | - | - | - | -1636.00 |
Investments in PPE | - | - | - | - | - | -1636.00 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 36.51 Thousand | 32.35 Thousand | 35.63 Thousand | - | - | 196.62 Thousand |
Debt repayment | -36.51 Thousand | -32.35 Thousand | -35.63 Thousand | - | - | -78.05 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | -226 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 36.51 Thousand | 64.71 Thousand | 71.27 Thousand | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | -4285.00 | 1785.00 | -1100.00 | 600.00 | - | -72.59 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | 4285.00 | 61.16 Thousand | 40.83 Thousand | 36 Thousand | 36.00 | 26 Thousand |
Cash at beginning of period | - | - | - | - | 255.00 | 2300.00 |
Cash at end of period | - | - | - | 36.60 | 291.60 | 125.00 |
Capital Expenditure | - | - | - | - | - | -1636.00 |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 36.60 | 36.60 | -2175.00 |
Free Cash Flow | -36.51 Thousand | -32.35 Thousand | -35.63 Thousand | 36.60 | 36.60 | -200.43 Thousand |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -25.25 Thousand | -15.68 Thousand | -92.22 Thousand | -25.56 Thousand | -19.94 Thousand | -19.43 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 18.99 Thousand | 15.25 Thousand | 55.71 Thousand | 13.66 Thousand | 13.94 Thousand | 14.77 Thousand |
Other non-cash items | 3.99 | 0.25 | -4.29 | -1.33 | -1.05 | -0.23 |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 6260.00 | 425.00 | 36.51 Thousand | 11.9 Thousand | 5993.00 | 4663.00 |
Debt repayment | -6260.00 | -425.00 | -36.51 Thousand | -11.9 Thousand | -5993.00 | -4663.00 |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 6.26 | 0.43 | 36.51 Thousand | 11.90 | 11.98 Thousand | 9326.00 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | 3990.00 | 255.00 | -4285.00 | -1334.00 | -1051.00 | -225.00 |
Inventory | - | - | - | - | - | - |
Other working capital | 15.00 | 15.00 | 4285.00 | 15 Thousand | 15 Thousand | 15 Thousand |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | - | - | - | - | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | -6260.00 | -425.00 | -36.51 Thousand | -11.9 Thousand | -5993.00 | -4663.00 |
ROK
JFEEF
IVCTF
6741
4991
PDLB